Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Suven Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:543064NSE Symbol: SUVENPHARP/E(TTM):42.92
ISIN Demat:INE03QK01018Div & Yield %:0.93EPS(TTM):14.99
Book Value(Rs):76.538791Market Cap ( Cr.):16377.44Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :     
Sales Turnover 1330.081320.221009.72833.79377.83
Excise Duty0.000.000.000.000.00
Net Sales1330.081320.221009.72833.79377.83
Other Income 44.55187.7914.2418.120.60
Stock Adjustments 20.9460.358.3711.0521.32
Total Income1395.571568.361032.33862.96399.75
EXPENDITURE :     
Raw Materials 421.36459.46310.32240.24124.52
Power & Fuel Cost71.3559.5544.2038.2418.06
Employee Cost 100.84100.4876.2365.1029.63
Other Manufacturing Expenses 101.19115.2590.7666.4933.83
Selling and Administration Expenses 52.3752.6244.9344.7216.23
Miscellaneous Expenses 13.4710.928.615.265.34
Less: Pre-operative Expenses Capitalised0.000.000.000.000.00
Total Expenditure760.59798.29575.05460.05227.60
Operating Profit634.99770.08457.28402.91172.15
Interest 12.758.5311.6621.812.79
Gross Profit622.24761.55445.62381.10169.36
Depreciation42.8439.1031.6423.5111.50
Profit Before Tax579.40722.45413.98357.59157.86
Tax142.45157.63101.7288.8133.17
Fringe Benefit tax0.000.000.000.000.00
Deferred Tax4.346.723.62-1.3015.42
Reported Net Profit432.60558.10308.65270.08109.27
Extraordinary Items 10.5514.532.514.730.11
Adjusted Net Profit422.05543.57306.14265.35109.16
Adjst. below Net Profit -0.26-0.76-0.84-13.90315.80
P & L Balance brought forward1276.39835.88568.52390.980.00
Statutory Appropriations 0.000.000.000.000.00
Appropriations 218.65116.8340.4678.6434.09
P & L Balance carried down1490.071276.39835.88568.52390.98
Dividend0.000.000.000.000.00
Preference Dividend0.000.000.000.000.00
Equity Dividend %600.00500.00200.00500.000.00
Earnings Per Share-Unit Curr16.9921.9212.1221.2220.60
Earnings Per Share(Adj)-Unit Curr16.9921.9212.1210.61NA
Book Value-Unit Curr68.7259.7441.8461.500.00